SCHEMBL21995424

SCHEMBL21995424

[CH2]Cc1ccc(C#N)cc1C

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.41
ALDH1A1 P00352 1/20 0.41
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
FFAR1 O14842 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36
AR P10275 4/20 0.36
LOXL2 Q9Y4K0 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
EGLN2 Q96KS0 3/20 0.34
HTR2A P28223 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2154771 0.83 CYP2A6 (0.44) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL2153680 0.83 CYP2A6 (0.44) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL12763619 0.82 CYP2A6 (0.48) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL3715551 0.80 CYP2A6 (0.41) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL20864209 0.80 CYP2A6 (0.41) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL410177 0.80 CYP2A6 (0.41) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL7212186 0.80 LOXL2 (0.47) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL25786464 0.80 CYP2A6 (0.41) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL1741193 0.79 CYP2A6 (0.38) CYP2A6ALDH1A1KDM5AKDM4CKDM5B
Hydrochloric Acid SCHEMBL20840172 0.78 LOXL2 (0.45) CYP2A6ALDH1A1KDM5AKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165252-A1 ACTIVE COMPOUND COMBINATIONS BAYER AKTIENGESELLSCHAFT (DE) 2023-06-01 US disclosed
US-20230054449-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2023-02-23 US disclosed
EP-3887362-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS Bayer Aktiengesellschaft (DE) 2021-10-06 EP disclosed
WO-2020109391-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2020-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165252-A1 ACTIVE COMPOUND COMBINATIONS CYP51A1, ERG28, BROX CYP2A6 370/4885ALDH1A1 2558/4885KDM5A 631/4885
US-20230054449-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS PNPO, TPMT, BLVRB CYP2A6 405/4885ALDH1A1 2740/4885KDM5A 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.